This weight-loss drug maker's stock is up 20% this year — and Barclays sees it going higher - CNBC

1 year ago 32
  1. This weight-loss cause maker's banal is up 20% this twelvemonth — and Barclays sees it going higher  CNBC
  2. Thursday's biggest expert calls connected Wall Street  CNBC
  3. Barclays says there's a large buying accidental successful Activision Blizzard aft blocked Microsoft deal, sees shares rallying 30%  CNBC
  4. This video crippled banal could conflict aft the blocking of Microsoft's Activision Blizzard takeover, BMO says  CNBC
  5. One online retailer volition get a sizable income boost from Bed Bath & Beyond's demise, Telsey Group estimates  CNBC
  6. View Full Coverage connected Google News
Read Entire Article